METABASIS THERAPEUT (NASDAQ:MBRX)
0.40
-0 (-0%)
| METABASIS THERAPEUT (NASDAQ:MBRX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $0.40 | 52 Week High | $1.15 | ||
| Open | $0.39 | 52 Week Low | $0.21 | ||
| Day High | $0.40 | P/E | N/A | ||
| Day Low | $0.38 | EPS | $-0.34 | ||
| Volume | 248,192 | ||||
| More MBRX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| LGND | 4 | MRK | 3 |
| JAZZ | 2 | NPSP | 2 |
| STAA | 2 | KO | 2 |
| LUB | 2 | PLXS | 2 |
| CPST | 2 | HGSI | 2 |
| JWN | 1 | TIN | 1 |
Entities who have mentioned MBRX
- Merriman Curhan Ford | View Related Stories »
- Dividend | View Related Stories »
- After-Hours Movers | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- 13G | View Related Stories »
- 13D | View Related Stories »
- UBS | View Related Stories »
- Jefferies & Co | View Related Stories »
- Davenport | View Related Stories »
- Wachovia | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- Brean Murray Carret & Co. | View Related Stories »
- Twitter | View Related Stories »
- Wellington Management | View Related Stories »
- Collins Stewart | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Morgan Stanley | View Related Stories »
- Piper Jaffray | View Related Stories »
- Deutsche Bank | View Related Stories »
- Raymond James | View Related Stories »
View All Major News StreetInsider.com Major News for MBRX
- Ligand Pharmaceuticals (LGND) To Acquire Metabasis Therapeutics (MBRX)
- Metabasis (MBRX) To Receive $6M Fee From Merck, But Still Warns About Its Future
- Metabasis Therapeutics (MBRX) Reports a Q1 Loss
View All ReportsStreetInsider.com Reports on MBRX
- Ligand Pharmaceuticals (LGND) To Acquire Metabasis Therapeutics (MBRX)
- Morning Movers 10/09: SCIL, MBRX, CAGC, AVNR, PSTA, SRZ, ELGX Higher; SPPI, ACOR, LXRX Lower
- Metabasis Therapeutics (MBRX) Sees Upside
- Morning Movers 6/11: STAA, CPST, HGSI, CHDX, MBRX, OBCI Higher; LULU, UNH, LUB, LTON, PNFP Lower
- STAA, MBRX, NPSP, HGSI, CPST, JAZZ, ESLR See Volume and Upside Price Action
View All Press ReleasesCompany Press Releases on MBRX
- Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com
- Metabasis Announces Ligand to Acquire Metabasis for Cash and Contingent Value Rights
- Ligand to Acquire Metabasis for Cash and Contingent Value Rights
StreetInsider Reports on MBRX by Category
View All BlogsBlogs on MBRX
- This Week in Biotech: More Treats than Tricks
- Equities Update: Mixed Finish for Major Averages
- 15 Breakout Stocks on Huge Volume
- Biotech Busy with Bevy of Small Deals
- Analyst upgrades, downgrades and initiations: GOOG, AA, FCX, SJM, TWC ...
View All FilingsSEC Filings on MBRX
- Form SC 13D METABASIS THERAPEUTICS Filed by: LIGAND PHARMACEUTICALS INC
- Form SC 13G/A METABASIS THERAPEUTICS Filed by: WELLINGTON MANAGEMENT CO LLP
- Form 8-K METABASIS THERAPEUTICS For: Oct 23
- Form 8-K METABASIS THERAPEUTICS For: Oct 14
- Form 8-K METABASIS THERAPEUTICS For: Oct 06
Comments on recent MBRX articles
Comments on MBRX
No comments are currently available.
on Oct 28, 2009
at 11:52 AM Class action How can a company make a deal to sell that takes its stock from $.91 to $ .41 overnight. Is that representing it's stockholders? How long do you think it will be till the class action suits start?
Article: Ligand Pharmaceuticals (LGND) To Acquire Metabasis Therapeutics (MBRX)
on Feb 20, 2008
at 03:42 PM INSM A $3.00 dollar stock trading below a $1.00.
Article: Analyst Call of the Year: Collins Stewart on Encysive (ENCY)